Acid-beta-glucosidase 3D structures
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| - | [[2wkl]], [[3gxd]], [[3gxi]], [[3gxm]], [[2v3f]], [[2nt0]], [[2nt1]], [[2j25]], [[2f61]], [[1ogs]], [[3rik]] – hABG – human<br /> | + | [[2wkl]], [[3gxd]], [[3gxi]], [[3gxm]], [[2v3f]], [[2nt0]], [[2nt1]], [[2j25]], [[2f61]], [[1ogs]], [[3rik]], [[6tjj]], [[6tn1]] – hABG – human<br /> |
[[3ke0]], [[3keh]] – hABG (mutant) <br /> | [[3ke0]], [[3keh]] – hABG (mutant) <br /> | ||
| - | [[2wcg]], [[3gxf]], [[2vt0]], [[2v3e]], [[2v3d]], [[1y7v]], [[3ril]], [[5lvx]], [[6moz]], [[6q6l]], [[6q6k]], [[6q6n]] – hABG + inhibitor<br /> | + | [[2wcg]], [[3gxf]], [[2vt0]], [[2v3e]], [[2v3d]], [[1y7v]], [[3ril]], [[5lvx]], [[6moz]], [[6q6l]], [[6q6k]], [[6q6n]], [[6ytp]], [[6ytr]], [[6yut]], [[6yv3]] – hABG + inhibitor<br /> |
[[2nsx]] – hABG + pharmacological chaperone<br /> | [[2nsx]] – hABG + pharmacological chaperone<br /> | ||
[[2xwd]], [[2xwe]] – hABG + nojirimycin derivative<br /> | [[2xwd]], [[2xwe]] – hABG + nojirimycin derivative<br /> | ||
| + | [[6z39]], [[6z3i]], [[7nwv]] – hABG + activity probe<br /> | ||
| + | [[6tjq]] – hABG + glucopyranoside derivative<br /> | ||
| + | [[6tjk]] – hABG + bis-tris propane<br /> | ||
[[Category: Topic Page]] | [[Category: Topic Page]] | ||
Revision as of 07:52, 18 August 2022
3D structures of Acid-beta-glucosidase
Updated on 18-August-2022
2wkl, 3gxd, 3gxi, 3gxm, 2v3f, 2nt0, 2nt1, 2j25, 2f61, 1ogs, 3rik, 6tjj, 6tn1 – hABG – human
3ke0, 3keh – hABG (mutant)
2wcg, 3gxf, 2vt0, 2v3e, 2v3d, 1y7v, 3ril, 5lvx, 6moz, 6q6l, 6q6k, 6q6n, 6ytp, 6ytr, 6yut, 6yv3 – hABG + inhibitor
2nsx – hABG + pharmacological chaperone
2xwd, 2xwe – hABG + nojirimycin derivative
6z39, 6z3i, 7nwv – hABG + activity probe
6tjq – hABG + glucopyranoside derivative
6tjk – hABG + bis-tris propane
